Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-118363

SVP, Chief Business Officer sold 32,960 shares at an average $4.97 ($163,866)

  • SVP, Chief Business Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Korbel Gregory Alan · SVP, Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-20 Sale : show line 1 in the form −5,460 $4.98 $27,191 17,167 D
2021-09-20 Exercise or conversion : show line 2 in the form +27,500 $0.92 $25,300 44,667 D
2021-09-20 Sale : show line 3 in the form −27,500 $4.97 $136,675 17,167 D
Open-market sales · 32,960 sh · avg $4.97 · $163,866

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-20 Exercise or conversion : show line 4 in the form Stock Option (right to Buy) −27,500 52,745 D
Loading xslF345X03/tm2127534-4_4seq1.xml…